245 related articles for article (PubMed ID: 28581641)
1. Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance.
Zhang L; Yang H; Zhang W; Liang Z; Huang Q; Xu G; Zhen X; Zheng LT
J Neurochem; 2017 Aug; 142(4):574-588. PubMed ID: 28581641
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
4. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
5. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
Zheng LT; Lee S; Yin GN; Mori K; Suk K
J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
[TBL] [Abstract][Full Text] [Related]
7. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
8. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
9. Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease.
Li H; Satriano J; Thomas JL; Miyamoto S; Sharma K; Pastor-Soler NM; Hallows KR; Singh P
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F414-28. PubMed ID: 26136559
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells.
Hwang JT; Lee M; Jung SN; Lee HJ; Kang I; Kim SS; Ha J
Carcinogenesis; 2004 Dec; 25(12):2497-507. PubMed ID: 15297373
[TBL] [Abstract][Full Text] [Related]
11. The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer.
Wang G; Yu Y; Wang YZ; Yin PH; Xu K; Zhang H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1231-1249. PubMed ID: 32985258
[TBL] [Abstract][Full Text] [Related]
12. 4-O-methylascochlorin, methylated derivative of ascochlorin, stabilizes HIF-1α via AMPK activation.
Jeong JH; Kang JH; Hwang SL; Cho HJ; Park KK; Park YY; Chung IK; Chang HW; Kim CH; Min KS; Kim HD; Magae J; Kang SS; Chang YC
Biochem Biophys Res Commun; 2011 Mar; 406(3):353-8. PubMed ID: 21329651
[TBL] [Abstract][Full Text] [Related]
13. Ablation of CD44 induces glycolysis-to-oxidative phosphorylation transition via modulation of the c-Src-Akt-LKB1-AMPKα pathway.
Nam K; Oh S; Shin I
Biochem J; 2016 Oct; 473(19):3013-30. PubMed ID: 27458252
[TBL] [Abstract][Full Text] [Related]
14. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming.
Gu R; Zhang F; Chen G; Han C; Liu J; Ren Z; Zhu Y; Waddington JL; Zheng LT; Zhen X
Brain Behav Immun; 2017 Feb; 60():206-219. PubMed ID: 27769915
[TBL] [Abstract][Full Text] [Related]
15. Silencing Nrf2 impairs glioma cell proliferation via AMPK-activated mTOR inhibition.
Jia Y; Wang H; Wang Q; Ding H; Wu H; Pan H
Biochem Biophys Res Commun; 2016 Jan; 469(3):665-71. PubMed ID: 26692480
[TBL] [Abstract][Full Text] [Related]
16. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.
Cheng SC; Quintin J; Cramer RA; Shepardson KM; Saeed S; Kumar V; Giamarellos-Bourboulis EJ; Martens JH; Rao NA; Aghajanirefah A; Manjeri GR; Li Y; Ifrim DC; Arts RJ; van der Veer BM; Deen PM; Logie C; O'Neill LA; Willems P; van de Veerdonk FL; van der Meer JW; Ng A; Joosten LA; Wijmenga C; Stunnenberg HG; Xavier RJ; Netea MG
Science; 2014 Sep; 345(6204):1250684. PubMed ID: 25258083
[TBL] [Abstract][Full Text] [Related]
17. METFORMIN MITIGATES SEPSIS-ASSOCIATED PULMONARY FIBROSIS BY PROMOTING AMPK ACTIVATION AND INHIBITING HIF-1α-INDUCED AEROBIC GLYCOLYSIS.
Zhong H; Tang R; Feng JH; Peng YW; Xu QY; Zhou Y; He ZY; Mei SY; Xing SP
Shock; 2024 Feb; 61(2):283-293. PubMed ID: 38010091
[TBL] [Abstract][Full Text] [Related]
18. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
[TBL] [Abstract][Full Text] [Related]
19. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
20. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
Lai JH; Jan HJ; Liu LW; Lee CC; Wang SG; Hueng DY; Cheng YY; Lee HM; Ma HI
Neuro Oncol; 2013 Oct; 15(10):1330-41. PubMed ID: 23911596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]